Category: The Readout

Investigators fault Lilly plant for manufacturing issues

January 22, 2024 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, government agencies, Health, Human Health, legal, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The Senate health committee looks into its first subpoena in 40 years

January 19, 2024 STAT Off Biotech, biotechnology, Business, Congress, coronavirus, drug development, drug prices, drug pricing, finance, government agencies, Health, Human Health, legal, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The XBI comedown after JPM

January 18, 2024 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, finance, Health, Health Tech, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The big any-day-now biotech news we’re keeping an eye on

January 17, 2024 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug prices, drug pricing, finance, Health, Health Tech, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, policy, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The four biotech stories you need to read this morning

January 16, 2024 STAT Off Biotech, biotechnology, Business, cancer, Congress, drug development, drug prices, drug pricing, FDA, finance, government agencies, Health, Human Health, Life Sciences, Medicine, patients, Pharma, Pharmaceuticals, policy, Politics, research, Science and Research, The Readout, vaccines

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Novartis reportedly decides to pass on Cytokinetics

January 12, 2024 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, government agencies, Health, Human Health, legal, Life Sciences, Medicine, mental health, Pharma, Pharmaceuticals, Politics, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The highs — and lows — of JPM 2024 you should pay attention to

January 11, 2024 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, genetics, global health, Health, Health Tech, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…

JPM Day 3 had a cautiously optimistic outlook

January 10, 2024 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug prices, drug pricing, Health, Health Tech, hospitals, Human Health, Life Sciences, Medicine, patients, Pharma, Pharmaceuticals, Politics, Science and Research, The Readout

In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…

JPM Day 2 has arrived. Here are the can’t-miss moments of the event so far

January 9, 2024 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug pricing, FDA, finance, genetics, government agencies, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, physicians, research, Science and Research, The Readout

In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…

This is the TLDR of JPM Day 1

January 8, 2024 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug prices, drug pricing, Health, health care, Health Tech, Human Health, jpm, JPM 2024, Life Sciences, Medicine, mental health, Pharma, Pharmaceuticals, public health, rare diseases, research, Science and Research, The Readout, Uncategorized

In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…

No pain data yet from Vertex, and sky high deal expectations at JPM 2024

January 7, 2024 STAT Off artificial intelligence, Biotech, biotechnology, Gilead Sciences, Human Health, JPM 2024, Life Sciences, Medicine, pain, Pharma, Science and Research, The Readout, Vertex

Want to stay on top of the science and politics driving biotech today? Sign up to…

Why did Allogene cancel two clinical trials for its off-the-shelf cell therapy?

January 5, 2024 STAT Off Biotech, biotechnology, cancer, CRISPR, drug development, FDA, Human Health, Life Sciences, Medicine, opioids, Pharma, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Why CG Oncology will be the first test of 2024’s IPO waters

January 4, 2024 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug prices, drug pricing, government agencies, Health, Human Health, legal, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Anavex’s slow journey to failure

January 3, 2024 STAT Off advocacy, Biotech, biotechnology, Business, drug development, drug prices, drug pricing, finance, government agencies, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The clock is ticking, and cytokinetics is running out of December

December 22, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, Health, Human Health, Life Sciences, Medicine, patients, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

BioMarin appeases an activist

December 21, 2023 STAT Off Biotech, biotechnology, Business, cancer, CRISPR, drug development, drug prices, drug pricing, FDA, finance, genetics, government agencies, Health, Human Health, legal, Life Sciences, Medicine, patients, Pharma, Pharmaceuticals, physicians, rare diseases, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The biotech updates you need to read today

December 19, 2023 STAT Off Biotech, biotechnology, Business, cancer, drug development, drug prices, drug pricing, finance, genetics, Health, hospitals, Human Health, legal, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive

December 18, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, Health, Human Health, legal, Life Sciences, Medicine, patients, Pharma, Pharmaceuticals, physicians, rare diseases, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

FDA chastens pet companies over antibiotics

December 15, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, government agencies, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Is it time to worry about Moderna?

December 14, 2023 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug prices, drug pricing, finance, genetics, Health, Human Health, Life Sciences, Medicine, obesity, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

A plot to solve the ‘whack-a-mole’ of drug discovery

December 13, 2023 STAT Off Biotech, biotechnology, Business, CRISPR, drug pricing, genetics, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, public health, rare diseases, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Tome Biosciences goes public today in another biotech megaround

December 12, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, genetics, government agencies, Health, Human Health, Life Sciences, Medicine, Pharma, policy, rare diseases, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Morning Rounds: Preterm birth rates vary across the U.S., with the highest in the Southeast

December 11, 2023 STAT Off Biotech, Business, cancer, CRISPR, genetics, government agencies, Health, Human Health, legal, Life Sciences, Medicine, patients, Pharmaceuticals, policy, public health, rare diseases, research, Science and Research, The Readout

Understand how science, health policy, and medicine shape the world everyday. Sign up for our…

The biotech news you missed from the weekend

December 11, 2023 STAT Off Biotech, biotechnology, Business, cancer, drug development, drug pricing, FDA, finance, genetics, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

CRISPR is about to make history. Here’s the 5-minute rundown of what to expect

December 8, 2023 STAT Off Biotech, biotechnology, Business, coronavirus, CRISPR, drug development, drug prices, drug pricing, FDA, genetics, Health, Human Health, Life Sciences, Medicine, patients, Pharma, Pharmaceuticals, Politics, rare diseases, research, Science and Research, The Readout, vaccines

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Eli Lilly’s latest $1.4 billion deal might come unglued

December 7, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, finance, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout, vaccines

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Why Cerevel Therapeutics has risen 50% in three days without changing anything

December 6, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, global health, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Carmot’s chance of beating the odds in the biotech market just ended

December 5, 2023 STAT Off Biotech, biotechnology, Business, cancer, children's health, Congress, drug development, drug prices, drug pricing, FDA, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, policy, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Novartis is building a new radioligand plant in China

December 4, 2023 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug prices, drug pricing, FDA, finance, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Johnson & Johnson bets heavy on AI-driven drug discovery

December 1, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug pricing, FDA, genetics, government agencies, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Do GLP-1s have a future treating alcoholism?

November 30, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, genetics, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Flagship Pioneering crosses the pond, opens a European front

November 29, 2023 STAT Off Biotech, biotechnology, Business, cancer, drug development, FDA, finance, genetics, government agencies, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Today’s biotech news roundup, in under 800 words

November 28, 2023 STAT Off Alzheimer's disease, Alzheimer’s, Biotech, biotechnology, dementia, drug development, drug prices, drug pricing, FDA, genetics, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

A new algorithm unveils CRISPR ‘treasure trove’

November 27, 2023 STAT Off artificial intelligence, Biotech, biotechnology, Business, CRISPR, drug development, drug prices, drug pricing, finance, genetics, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Medtronic isn’t afraid of Wegovy’s potential to disrupt

November 22, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, government agencies, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Bayer’s new CEO was dealt a duo of ‘clearing events.’ Tough choices lie ahead

November 21, 2023 STAT Off Alzheimer's disease, Alzheimer’s, Biotech, biotechnology, Business, drug development, drug prices, drug pricing, finance, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout, vaccines

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Merck cough drug doesn’t pass panel scrutiny

November 20, 2023 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug pricing, FDA, government agencies, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The return of biotech’s “bump factor” amid an economic downturn

November 17, 2023 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug pricing, FDA, finance, genetics, Health, health care, Human Health, Life Sciences, Medicine, Pharmaceuticals, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

How do we know Alzheimer’s drugs ‘work’?

November 16, 2023 STAT Off Biotech, biotechnology, Business, dementia, FDA, genetics, government agencies, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The apparently strong correlation between biotech stocks and the price of eggs, explained

November 15, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug pricing, finance, government agencies, health care, Human Health, Life Sciences, Medicine, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

November 14, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, global health, government agencies, Health, Human Health, Life Sciences, Medicine, patients, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Novo Nordisk has its sights on becoming a major player in heart disease

November 13, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, finance, global health, Health, Human Health, Life Sciences, Medicine, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The first vaccine for the increasingly prevalent chikungunya virus is here

November 10, 2023 STAT Off Biotech, biotechnology, Business, cancer, drug development, FDA, finance, global health, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, rare diseases, research, Science and Research, The Readout, vaccines

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Eli Lilly tries a rare tactic: competing on price

November 9, 2023 STAT Off Biotech, biotechnology, cancer, genetics, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, policy, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

BioMarin’s new CEO inherits a profitable company, a pioneering gene therapy, and a brewing activist challenge

November 8, 2023 STAT Off Biotech, biotechnology, cancer, drug pricing, finance, genetics, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, public health, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Your morning biotech news roundup

November 7, 2023 STAT Off Biotech, biotechnology, CRISPR, drug development, drug prices, drug pricing, FDA, finance, global health, government agencies, Health, health care, Human Health, Life Sciences, Medicine, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

XBI biotech index rises, giving investors a shred of hope

November 6, 2023 STAT Off Biotech, biotechnology, drug development, drug prices, drug pricing, finance, Health, health care, Human Health, Life Sciences, Medicine, Pharma, public health, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Shrinking COVID vaccine sales has Moderna course-correcting

November 3, 2023 STAT Off Biotech, biotechnology, Congress, drug development, drug prices, drug pricing, FDA, finance, Health, health care, Human Health, insurance, Life Sciences, Medicare, Medicine, Pharma, Pharmaceuticals, policy, Politics, public health, research, Science and Research, The Readout, vaccines

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis

November 2, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug pricing, FDA, finance, Health, health care, Human Health, insurance, Life Sciences, Medicine, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Gene editing has had a big week in the spotlight. Here’s what’s going on

November 1, 2023 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug pricing, FDA, finance, gene therapy, genetics, Health, Human Health, Life Sciences, Medicine, Pharma, public health, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…